Development of TDP-43 inhibitors for treating ALS, FTD, and Alzheimer's disease

被引：0
|
作者：
Zhang, Chengliang [1 ]
机构：
[1] Alteron Therapeut Inc, New York, NY USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
148
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] TDP-43 in FTD and ALS
    Neumann, M.
    BRAIN PATHOLOGY, 2010, 20 : 7 - 7
  • [2] Cryptic exon splicing repression by TDP-43 represents its major function compromised in Alzheimer's disease and ALS/FTD
    Chen, Liam
    Sun, Mingkuan
    Bell, Robert
    Pletnikova, Olga
    Troncoso, Juan
    Wong, Philip
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (06): : 492 - 492
  • [3] Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD
    Copley, Katie
    Smirnov, Ashleigh
    Mayne, Leland
    Wang, Yuanhang
    Black, Ben E.
    Shorter, James
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 485A - 486A
  • [4] Developing RNA Therapeutics for TDP-43 Proteinopathy in ALS/FTD
    Copley, Katie E.
    Smirnov, Ashleigh
    Shorter, James
    FASEB JOURNAL, 2022, 36
  • [5] TDP-43 Pathology in Alzheimer’s Disease
    Axel Meneses
    Shunsuke Koga
    Justin O’Leary
    Dennis W. Dickson
    Guojun Bu
    Na Zhao
    Molecular Neurodegeneration, 16
  • [6] The Role of TDP-43 in Alzheimer’s Disease
    Xiao-Long Chang
    Meng-Shan Tan
    Lan Tan
    Jin-Tai Yu
    Molecular Neurobiology, 2016, 53 : 3349 - 3359
  • [7] TDP-43 Pathology in Alzheimer's Disease
    Meneses, Axel
    Koga, Shunsuke
    O'Leary, Justin
    Dickson, Dennis W.
    Bu, Guojun
    Zhao, Na
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [8] The Role of TDP-43 in Alzheimer's Disease
    Chang, Xiao-Long
    Tan, Meng-Shan
    Tan, Lan
    Yu, Jin-Tai
    MOLECULAR NEUROBIOLOGY, 2016, 53 (05) : 3349 - 3359
  • [9] Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD
    Cao, Tianyu
    Mallika, Aswathy
    Sinha, Irika
    Baghel, Meghraj
    Irwin, Katie
    Ling, Jonathan
    Wong, Philip C.
    MOLECULAR THERAPY, 2024, 32 (04) : 487 - 487
  • [10] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Hayes, Lindsey R.
    Kalab, Petr
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1061 - 1084
12345